TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Norsk Diabetessenter For Behandling og Opplæring
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
12,492
|
12,118
|
11,496 |
Financial expenses |
2
|
0
|
5 |
Earnings before taxes |
-615
|
371
|
178 |
Total assets |
15,117
|
15,946
|
15,349 |
Current assets |
10,099
|
10,782
|
10,032 |
Current liabilities |
2,027
|
2,241
|
2,014 |
Equity capital |
13,090
|
13,705
|
13,335 |
- share capital |
110
![]() |
110
![]() |
110 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
86.6%
|
85.9%
|
86.9% |
Turnover per employee | |||
Profit as a percentage of turnover |
-4.9%
|
3.1%
|
1.5% |
Return on assets (ROA) |
-4.1%
|
2.3%
|
1.2% |
Current ratio |
498.2%
|
481.1%
|
498.1% |
Return on equity (ROE) |
-4.7%
|
2.7%
|
1.3% |
Change turnover |
374
|
622
|
-420 |
Change turnover % |
3%
|
5%
|
-4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.